BR0307262A - Method of Providing Tuberculosis Prophylaxis in HIV-Positive Individuals - Google Patents

Method of Providing Tuberculosis Prophylaxis in HIV-Positive Individuals

Info

Publication number
BR0307262A
BR0307262A BRPI0307262-2A BR0307262A BR0307262A BR 0307262 A BR0307262 A BR 0307262A BR 0307262 A BR0307262 A BR 0307262A BR 0307262 A BR0307262 A BR 0307262A
Authority
BR
Brazil
Prior art keywords
providing
positive individuals
hiv
tuberculosis
prophylaxis
Prior art date
Application number
BRPI0307262-2A
Other languages
Portuguese (pt)
Inventor
Bakulesh Mafatlal Khamar
Original Assignee
Bakulesh Mafatlal Khamar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bakulesh Mafatlal Khamar filed Critical Bakulesh Mafatlal Khamar
Publication of BR0307262A publication Critical patent/BR0307262A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"MéTODO DE PROVER PROFILAXIA PARA TUBERCULOSE EM INDIVìDUOS HIV POSITIVOS". A presente invenção se refere a um método para prover profilaxia para tuberculose em indivíduos HIV positivos. De acordo com a presente invenção, vacina feita a partir do 'Mycobacterium w' (Mw) é reconhecida como útil em prover profilaxia contra tuberculose em indivíduos HIV positivos."METHOD OF PROVIDING PROPHILAXIA FOR TUBERCULOSIS IN HIV POSITIVE INDIVIDUALS". The present invention relates to a method for providing tuberculosis prophylaxis in HIV positive individuals. In accordance with the present invention, vaccine made from Mycobacterium w (Mw) is recognized as useful in providing tuberculosis prophylaxis in HIV positive individuals.

BRPI0307262-2A 2002-01-29 2003-01-27 Method of Providing Tuberculosis Prophylaxis in HIV-Positive Individuals BR0307262A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN81MU2002 2002-01-29
PCT/IB2003/000207 WO2003063897A1 (en) 2002-01-29 2003-01-27 Method of providing prophylaxis for tuberculosis in hiv positive individuals

Publications (1)

Publication Number Publication Date
BR0307262A true BR0307262A (en) 2006-12-19

Family

ID=27638225

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0307262-2A BR0307262A (en) 2002-01-29 2003-01-27 Method of Providing Tuberculosis Prophylaxis in HIV-Positive Individuals

Country Status (8)

Country Link
EP (1) EP1478391A1 (en)
JP (1) JP2006502090A (en)
AP (1) AP2004003109A0 (en)
BR (1) BR0307262A (en)
CA (1) CA2474794A1 (en)
EA (1) EA200400997A1 (en)
GB (1) GB2400560A (en)
WO (1) WO2003063897A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003075825A2 (en) * 2002-03-08 2003-09-18 Modi, Rajiv, Indravadan The method of treating tuberculosis
ES2231037B1 (en) 2003-10-31 2005-12-16 Archivel Technologies, Sl USEFUL IMMUNOTHERAPIC AGENT FOR THE COMBINED TREATMENT OF TUBERCULOSIS IN ASSOCIATION WITH OTHER PHARMACOS.
ES2307402B1 (en) * 2006-10-30 2009-09-30 Archivel Farma, S.L. PROFILACTIC VACCINE AGAINST TUBERCULOSIS.
JP2010531347A (en) * 2007-06-28 2010-09-24 カディラ ファーマシューティカルズ リミテッド Mitogen-activated protein kinase modulator

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9219425D0 (en) * 1992-09-14 1992-10-28 Univ London Therapeutic agent and its use
GB8918206D0 (en) * 1989-08-09 1989-09-20 Nat Inst Immunology Tuberculosis vaccine
AU2003209533A1 (en) * 2002-03-08 2003-09-22 Bakulesh Mafatlal Khamar Process of manufacturing pharmaceutical composition useful for management of tuberculosis

Also Published As

Publication number Publication date
WO2003063897A1 (en) 2003-08-07
GB2400560A (en) 2004-10-20
GB0418776D0 (en) 2004-09-22
EA200400997A1 (en) 2005-12-29
AP2004003109A0 (en) 2004-09-30
WO2003063897A8 (en) 2005-03-31
CA2474794A1 (en) 2003-08-07
JP2006502090A (en) 2006-01-19
EP1478391A1 (en) 2004-11-24

Similar Documents

Publication Publication Date Title
CY1119921T1 (en) Biochemical Stabilized Trimmeric Vaccine HIV-1 Vaccine
TN2010000212A1 (en) Inhibitors of human immunodeficiency virus replication
ECSP078066A (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF SYMPTOMS RELATED TO THE CYCLE
AP2011005541A0 (en) HIV vaccine based on targeting maximized GAG and NEF to dendritic cells.
MY169767A (en) Needle safety device
BRPI0510129A (en) ceramic body, process to produce the same and process to produce an aluminum oxynitride powder
EA200500225A1 (en) METHOD OF ACHIEVING RESISTANCE TO PATHOGENS IN PLANTS
GEP20156368B (en) Non-nucleoside reverse transcriptase inhibitors
ATE442375T1 (en) CYTARABINE MONOPHOSPHATE PRODRUGS
BR0108210A (en) Vaccine against human immunodeficiency virus
MX2009006118A (en) Personal care composition comprising a silicone elastomer.
BRPI0416534A (en) multiparticulate compositions with improved stability
BR0307262A (en) Method of Providing Tuberculosis Prophylaxis in HIV-Positive Individuals
MY160697A (en) A dental appliance
BRPI0515939A (en) hydrogen peroxide generator
WO2005089231A3 (en) Enhanced activity of hiv vaccine using a second generation immunomodulatory oligonucleotide
MX2007002875A (en) Biotinylated hexadecasaccharides, preparation and use thereof.
DK1305037T3 (en) Painkiller
DK1476058T3 (en) Vegetable peels
MX2009003976A (en) Drill for dental use and with modulated inertia.
PT1357932E (en) CRYSTALLINE MODIFICATION OF A CYCLIC DEPSIPEPTIDO WITH IMPROVED EFFICIENCY
BRPI0511550A (en) UI action processing using a novelty status
ATE551036T1 (en) CONDOM PACKAGING
ITMI20050614A1 (en) PROCESS FOR THE PURIFICATION OF 10-DEACETYLBACCHATIN III FROM 10-DEACETIL-2-DEBENZOYL-2-PENTENOYLABACCATIN III
WO2008063586A3 (en) Multicomponent vaccine

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4O, 5O, 6O E 7O ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2047 DE 30/03/2010.